(Q33832672)

29 July 2017

1 reference

title

Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature (English)

1 reference

29 July 2017

1 reference

Schulz GM

1

1 reference

PubMed ID

10665513

29 July 2017

Grant MK

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

Journal of Communication Disorders

29 July 2017

1 reference

29 July 2017

33

1 reference

29 July 2017

59-88

1 reference

29 July 2017

1

1 reference

Articulatory deficits in parkinsonian dysarthria: an acoustic analysis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech symptoms associated with early signs of Shy Drager syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech functions of the thalamus inferred from the effects of thalamotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Treatment of Parkinson hypophonia with percutaneous collagen augmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

How common is dementia in Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

A CRITICAL ANALYSIS OF THE EFFECTS OF TRIHEXYPHENIDYL (ARTANE) ON THE COMPONENTS OF THE PARKINSONIAN SYNDROME

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech problems in parkinsonian patients undergoing anterior choroidal artery occlusion or chemopallidectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE: I. INTENSITY, PITCH, AND DURATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE. II. PHYSIOLOGICAL SUPPORT FOR SPEECH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

SPEECH CHARACTERISTICS OF PATIENTS WITH PARKINSON'S DISEASE. 3. ARTICULATION, DIADOCHOKINESIS, AND OVER-ALL SPEECH ADEQUACY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Stop consonant production in isolated and repeated syllables in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Letter: Peak-dose dysphonia in parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech disorders of Parkinsonism: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Clusters of Deviant Speech Dimensions in the Dysarthrias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Differential Diagnostic Patterns of Dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Stereotactic pallidotomy for treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Cinegraphic observations of laryngeal function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Vocal Fold Paresis in Shy-Drager Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Sequence heterogeneity in Parkinsonian speech.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Regulation of parkinsonian speech volume: the effect of interlocuter distance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Unilateral versus bilateral simultaneous posteroventral pallidotomy in subgroups of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Posteroventral medial pallidotomy in advanced Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Effect of L-dopa on speech in Parkinsonism : An EMG study of labial articulatory function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Frequency and Cooccurrence of Vocal Tract Dysfunctions in the Speech of a Large Sample of Parkinson Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech timing in Parkinson's and Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Fetal nigral transplantation as a therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Success and problems of long-term levodopa therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Asymmetric effects of thalamic stimulation on rate of speech

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Periodicity of speech in Parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Clinical and acoustical variability in hypokinetic dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

The Rehabilitation Of Adults With Dysarthric Speech

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Parkinson’s Disease: Motor-Speech Behavior in a Selected Group of Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech defects of parkinsonian patients: Effects of levodopa therapy on speech intelligibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Acceleration and Weakness in Parkinsonian Dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech representation in ventrolateral thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

The Parkinson larynx: tremor and videostroboscopic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech disturbances following stereotaxic surgery in ventrolateral thalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Handwriting and speech changes across the levodopa cycle in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Effect of thalamotomy and levodopa therapy on the speech of Parkinson patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Comparison of two forms of intensive speech treatment for Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech changes in parkinsonism during L-dopa therapy: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

A microcomputer-based wearable biofeedback device to improve transfer of treatment in parkinsonian dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech impairment in Parkinson's disease is improved by transcranial application of electromagnetic fields

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

The effects on speech and language of stereotactical stimulation in thalamus and corpus callosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Voice and speech characteristics of persons with Parkinson's disease pre- and post-pallidotomy surgery: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Evidence for an apparent sensory speech disorder in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Intensive voice treatment in Parkinson disease: laryngostroboscopic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech dysfunction in early Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Epidemiology of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Pallidal and thalamic surgery for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Pallidal stimulation: an alternative to pallidotomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Impairment of temporal organization of speech in basal ganglia diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Speech changes in Parkinson's disease during treatment with L-dopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

Treatment of Non Fluent Speech Resulting from Neurological Disease–Treatment of Dysarthria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

7 January 2021

Investigations into speech disturbances following stereotaxic surgery for Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

1 reference

7 January 2021

Patterns of Dysarthric Movements in Patients with Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

7 January 2021

Speech therapy and Parkinson's disease: a review and further data

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9924%2899%2900025-8

1 reference

7 January 2021

10.1016/S0021-9924(99)00025-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10665513